Literature DB >> 24081430

Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - is it time for a more individual approach?

Hauke Sebastian Heinzow1, Jens G Brockmann, Michael Köhler, Heiner H Wolters, Norbert Senninger, Hartmut Schmidt, Tobias Meister.   

Abstract

BACKGROUND: This study evaluated the effect of liver transplantation (LTX) and STACE on overall survival in palliative patients with HCC exceeding Milan criteria.
MATERIAL AND METHODS: At a single center 63 HCC patients exceeding Milan criteria were retrospectively analyzed. Forty patients underwent STACE as palliative therapy modality and 23 palliative patients were scheduled for LTX. The primary endpoint was overall patient survival. Statistical analysis included Kaplan-Meier method, log rank, chi squared tests and Cox regression model for the identification of prognostic factors.
RESULTS: There was no significant difference when comparing the 2 groups (LTX vs. no LTX) in terms of Child classification, co-morbidities, underlying disease, and sex. Overall survival was significantly prolonged after LTX was performed (p=0.012). In the Cox regression model, LTX (p=0.021), LTX <3Mo (p=0.047), CHILD stage (p=0.007), AFP (p=0.020), and tumor size of largest HCC nodule <40 mm (p=0.028) were independent prognostic factors for survival.
CONCLUSIONS: Palliative patients beyond Milan have a significant survival benefit after they received early liver transplantation in comparison with STACE. The current approach to waiting list candidacy based on Milan criteria should be modified with a more individualized approach that considers age, AFP level, and tumor size.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081430     DOI: 10.12659/AOT.884018

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  4 in total

1.  Traumatic breast transposal to the abdominal wall: A case report.

Authors:  Mei Yang; Zhe Xu; Qiulin Liao; Hong Wang
Journal:  Oncol Lett       Date:  2014-07-01       Impact factor: 2.967

2.  Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study.

Authors:  Hui-Zhou Li; Jie Tan; Tian Tang; Tian-Zhi An; Jun-Xiang Li; Yu-Dong Xiao
Journal:  J Hepatocell Carcinoma       Date:  2021-11-01

Review 3.  Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.

Authors:  A Kornberg
Journal:  ISRN Hepatol       Date:  2014-03-04

4.  Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis.

Authors:  Houqiao Bai; Peng Gao; Hao Gao; Guangxi Sun; Chonghai Dong; Jian Han; Guosheng Jiang
Journal:  Med Sci Monit       Date:  2016-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.